Lara Gonzalez-Freire
Overview
Explore the profile of Lara Gonzalez-Freire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seijas-Amigo J, Mauriz-Montero M, Suarez-Artime P, Gayoso-Rey M, Reyes-Santias F, Estany-Gestal A, et al.
Diseases
. 2024 Oct;
12(10).
PMID: 39452487
The primary objective of this study was to conduct a cost-utility analysis of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in real-world, comparing their use with standard care for managing...
2.
Seijas-Amigo J, Mauriz-Montero M, Suarez-Artime P, Gayoso-Rey M, Estany-Gestal A, Casas-Martinez A, et al.
Am J Cardiovasc Drugs
. 2023 Aug;
23(5):583-593.
PMID: 37612529
Introduction: The cognitive safety of monoclonal antibody proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) has been established in clinical trials, but not yet in real-world observational studies. We assessed the...
3.
Gonzalez-Freire L, Davila-Pousa M, Batalla-Cebey A, Crespo-Diz C
Farm Hosp
. 2022 Apr;
46(2):51-56.
PMID: 35379096
Objective: Optimization of a topical formula of N-acetylcysteine and urea for the topical treatment of ichthyosis. Method: We reviewed the chemical structure of the N-acetylcysteine molecule and its metabolic processes....
4.
Seijas-Amigo J, Gayoso-Rey M, Mauriz-Montero M, Suarez-Artime P, Casas-Martinez A, Dominguez-Guerra M, et al.
Clin Investig Arterioscler
. 2022 Mar;
34(5):245-252.
PMID: 35287972
Objectives: MEMOGAL study (NCT04319081) is aimed at evaluating changes in cognitive function in patients treated with PCSK9 inhibitors (PCSK9i). This is the first analysis: (1) discussion about the role of...
5.
Gonzalez-Freire L, Gimenez-Candela R, Castro-Luaces S, Veiga-Villaverde A, Crespo-Diz C
Farm Hosp
. 2021 Jul;
45(4):165-169.
PMID: 34218760
Objective: Main objective: Describe the effectiveness and safety of baricitinib and tofacitinib in patients diagnosed with rheumatoid arthritis in our hospital. Secondary Objective: Analyse whether there are differences between the...
6.
Gayoso-Rey M, Diaz-Trastoy O, Romero-Ventosa E, Garcia-Beloso N, Gonzalez-Freire L, Lorenzo-Lorenzo K, et al.
Clin Ther
. 2021 Mar;
43(4):e111-e121.
PMID: 33712271
Purpose: To evaluate the effectiveness, adverse reactions, and adherence to treatment of hypolipidemic inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9is) in a context of real clinical practice. Methods: We...
7.
Boullosa-Lale S, Gonzalez-Freire L, Martinez-Martinez L, Crespo-Diz C
Farm Hosp
. 2021 Mar;
45(2):73-76.
PMID: 33709887
Objective: Dimethyl fumarate is a medication approved for the treatment of relapsing-remitting multiple sclerosis. The purpose of the study was to evaluate the safety and persistence of dimethyl fumarate in ...
8.
Vazquez-Blanco S, Gonzalez-Freire L, Davila-Pousa M, Crespo-Diz C
Farm Hosp
. 2018 Nov;
42(6):221-227.
PMID: 30381041
Objective: pH is a critical factor for all those medications prepared as aqueous liquid forms, because it has an impact on the solubility of the molecule, determining the stability of...
9.
Campano-Perez I, Olivera-Fernandez R, Gonzalez-Freire L, Crespo-Diz C
Farm Hosp
. 2018 Jan;
42(1):16-19.
PMID: 29306308
Objective: To descrive the use of therapeutic plasma exchange in several pathologies and its adjustment to international reference guides. Method: Observational, descriptive, retrospective study, of all the patients that received...